Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes

Vidthiya Jeyanathan; Sam Afkhami; Michael R D'Agostino; Anna Zganiacz; Xueya Feng; Matthew S Miller; Mangalakumari Jeyanathan; Michael R Thompson; Zhou Xing

doi:10.3389/fimmu.2023.1151809

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes

Front Immunol. 2023 Feb 7:14:1151809. doi: 10.3389/fimmu.2023.1151809. eCollection 2023.

Authors

Vidthiya Jeyanathan^{1

2}, Sam Afkhami^{1

2}, Michael R D'Agostino^{1

3}, Anna Zganiacz^{1

2}, Xueya Feng^{1

2}, Matthew S Miller^{1

3}, Mangalakumari Jeyanathan^{1

2}, Michael R Thompson⁴, Zhou Xing^{1

2}

Affiliations

¹ McMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research, Hamilton, ON, Canada.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.
³ Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
⁴ Department of Chemical Engineering, McMaster University, Hamilton, ON, Canada.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.860399.].

Keywords: Adenovirus-vectored vaccine; T cells; Tuberculosis; biodistribution; endotracheal; intranasal; mucosal immunity; respiratory mucosal immunization.

Publication types

Published Erratum